Sun Pharmaceutical Industries has launched its innovative biologic drug, ILUMYA, in India for moderate-to-severe plaque psoriasis. This novel treatment, Tildrakizumab, has a proven track record globally for providing significant and sustained skin clearance.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/e5Ki80u
via IFTTT
No comments:
Post a Comment